Angélique Levoye

2.4k total citations
25 papers, 1.9k citations indexed

About

Angélique Levoye is a scholar working on Molecular Biology, Oncology and Endocrine and Autonomic Systems. According to data from OpenAlex, Angélique Levoye has authored 25 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Endocrine and Autonomic Systems. Recurrent topics in Angélique Levoye's work include Receptor Mechanisms and Signaling (8 papers), Chemokine receptors and signaling (7 papers) and Circadian rhythm and melatonin (5 papers). Angélique Levoye is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Chemokine receptors and signaling (7 papers) and Circadian rhythm and melatonin (5 papers). Angélique Levoye collaborates with scholars based in France, Spain and Switzerland. Angélique Levoye's co-authors include Karl Balabanian, Ralf Jockers, Françoise Bachelerie, Françoise Baleux, Bernard Lagane, Mohammed Akli Ayoub, Philippe Delagrange, Jean‐Luc Guillaume, Julie Dam and Cyril Couturier and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The EMBO Journal.

In The Last Decade

Angélique Levoye

25 papers receiving 1.9k citations

Peers

Angélique Levoye
Angélique Levoye
Citations per year, relative to Angélique Levoye Angélique Levoye (= 1×) peers Shun‐ichiro Matsumoto

Countries citing papers authored by Angélique Levoye

Since Specialization
Citations

This map shows the geographic impact of Angélique Levoye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angélique Levoye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angélique Levoye more than expected).

Fields of papers citing papers by Angélique Levoye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angélique Levoye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angélique Levoye. The network helps show where Angélique Levoye may publish in the future.

Co-authorship network of co-authors of Angélique Levoye

This figure shows the co-authorship network connecting the top 25 collaborators of Angélique Levoye. A scholar is included among the top collaborators of Angélique Levoye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angélique Levoye. Angélique Levoye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Camus, Stéphane M., Vincent Duval, Paul Alayrac, et al.. (2022). Splenic Marginal Zone B Lymphocytes Regulate Cardiac Remodeling After Acute Myocardial Infarction in Mice. Journal of the American College of Cardiology. 79(7). 632–647. 39 indexed citations
2.
Alayrac, Paul, Vincent Duval, Mathilde Lemitre, et al.. (2022). Role of tissue resident VSIG4+ macrophages in cardiac remodeling after acute myocardial infarction in mice. Archives of Cardiovascular Diseases Supplements. 14(2). 168–168. 1 indexed citations
3.
Duval, Vincent, Paul Alayrac, Jean‐Sébastien Silvestre, & Angélique Levoye. (2022). Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases. Frontiers in Endocrinology. 13. 906586–906586. 26 indexed citations
4.
Tran‐Dinh, Alexy, Angélique Levoye, C. David, et al.. (2020). High-Density Lipoprotein Therapy in Stroke: Evaluation of Endothelial SR-BI-Dependent Neuroprotective Effects. International Journal of Molecular Sciences. 22(1). 106–106. 21 indexed citations
5.
Bernadat, Guillaume, Martin Gustavsson, Erika Cecon, et al.. (2020). Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors. Journal of Leukocyte Biology. 107(6). 1123–1135. 16 indexed citations
6.
Levoye, Angélique, Jurriaan M. Zwier, Martin Cottet, et al.. (2015). A Broad G Protein-Coupled Receptor Internalization Assay that Combines SNAP-Tag Labeling, Diffusion-Enhanced Resonance Energy Transfer, and a Highly Emissive Terbium Cryptate. Frontiers in Endocrinology. 6. 167–167. 54 indexed citations
7.
Moreno, Juan Antonio, Almudena Ortega‐Gómez, Alfonso Rubio‐Navarro, et al.. (2014). High-Density Lipoproteins Potentiate α1-Antitrypsin Therapy in Elastase-Induced Pulmonary Emphysema. American Journal of Respiratory Cell and Molecular Biology. 51(4). 536–549. 50 indexed citations
8.
Leloire, Audrey, et al.. (2010). Evidence for leptin receptor isoforms heteromerization at the cell surface. FEBS Letters. 584(11). 2213–2217. 25 indexed citations
9.
Levoye, Angélique, Karl Balabanian, Françoise Baleux, Françoise Bachelerie, & Bernard Lagane. (2009). CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood. 113(24). 6085–6093. 487 indexed citations
10.
Rueda, Patricia, Karl Balabanian, Bernard Lagane, et al.. (2008). The CXCL12γ Chemokine Displays Unprecedented Structural and Functional Properties that Make It a Paradigm of Chemoattractant Proteins. PLoS ONE. 3(7). e2543–e2543. 61 indexed citations
11.
Balabanian, Karl, Angélique Levoye, Bernard Lagane, et al.. (2008). Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling. Journal of Clinical Investigation. 118(3). 1074–84. 102 indexed citations
12.
Guillaume, Jean‐Luc, Avais M. Daulat, Pascal Maurice, et al.. (2008). The PDZ Protein Mupp1 Promotes Gi Coupling and Signaling of the Mt1 Melatonin Receptor. Journal of Biological Chemistry. 283(24). 16762–16771. 66 indexed citations
13.
Levoye, Angélique & Ralf Jockers. (2007). Alternative drug discovery approaches for orphan GPCRs. Drug Discovery Today. 13(1-2). 52–58. 24 indexed citations
14.
Levoye, Angélique & Ralf Jockers. (2007). L’hétérodimérisation des récepteurs couplés aux protéines G. médecine/sciences. 23(8-9). 746–750. 2 indexed citations
15.
Chen, Patty, Angélique Levoye, Avais M. Daulat, et al.. (2007). Detection of the human GPR50 orphan seven transmembrane protein by polyclonal antibodies mapping different epitopes. Journal of Pineal Research. 43(1). 10–15. 19 indexed citations
16.
Levoye, Angélique, Ralf Jockers, Mohammed Akli Ayoub, et al.. (2006). Are G Protein‐Coupled Receptor Heterodimers of Physiological Relevance?—Focus on Melatonin Receptors. Chronobiology International. 23(1-2). 419–426. 42 indexed citations
17.
Levoye, Angélique, Julie Dam, Mohammed Akli Ayoub, et al.. (2006). The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. The EMBO Journal. 25(13). 3012–3023. 264 indexed citations
18.
Levoye, Angélique, Julie Dam, Mohammed Akli Ayoub, Jean‐Luc Guillaume, & Ralf Jockers. (2006). Do orphan G‐protein‐coupled receptors have ligand‐independent functions?. EMBO Reports. 7(11). 1094–1098. 100 indexed citations
19.
Levoye, Angélique, Bernard Mouillac, Gilles Rivière, et al.. (2005). Cloning, expression and pharmacological characterization of a vasopressin-related receptor in an annelid, the leech Theromyzon tessulatum. Journal of Endocrinology. 184(1). 277–289. 18 indexed citations
20.
Ayoub, Mohammed Akli, Angélique Levoye, Philippe Delagrange, & Ralf Jockers. (2004). Preferential Formation of MT1/MT2 Melatonin Receptor Heterodimers with Distinct Ligand Interaction Properties Compared with MT2 Homodimers. Molecular Pharmacology. 66(2). 312–321. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026